A novel device for deep-inspiration breath hold (dibh): results from a single institution phase ii clinical trial for left-sided breast cancer patients

ConclusionThe validation of the device within the phase II clinical trial demonstrates that it offers reliable, stable, repeatable, and reproducible breast cancer treatments in DIBH with its dosimetric benefits.
Source: Practical Radiation Oncology - Category: Cancer & Oncology Source Type: research